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and 189, and VEGF receptors 1 and 2 in three experimental settings (A, B and C). We compared inter-
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was localised and quantified. Pregnant heifers displayed lower intercaruncular endometrial mRNA expres-
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lium and in tunica muscularis of blood vessels. At Day 15, caruncular endometrium displayed higher
VEGFA mRNA expression than intercaruncular endometrium (p < 0.05). Intercaruncular endometrial
VEGFA protein at Day 18 was higher in abundance in SCNT than in IVF (p = 0.038). Therefore,
during preimplantation in cattle, there may be a need for timely physiological reduction in intercarun-
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Abstract: Vascular endothelial growth factor A (VEGFA) plays a critical angiogenic role in the
endometrium of placentalia during preimplantation. The role of VEGFA and its receptors is
not fully characterised in bovine reproduction. We analysed the mRNA expression of VEGFA
isoforms 121, 165 and 189, and VEGF receptors 1 and 2 in three experimental settings (A, B and
C). We compared intercaruncular endometrium of cyclic to pregnant heifers at Days 12, 15 and 18
post insemination (Day 0), and between Day 15 and Day 18 conceptuses (A). We further compared
caruncular versus intercaruncular endometrium at Day 15 (B), and endometrium of heifers carrying
embryos originating from somatic cell nuclear transfer (SCNT) versus in vitro fertilisation (IVF) at
Day 18 (C). Endometrial VEGFA protein was localised and quantified. Pregnant heifers displayed
lower intercaruncular endometrial mRNA expression of VEGFA-121 (p = 0.045) and VEGFA-189
(p = 0.009) as well as lower VEGFA protein abundance (p < 0.001) at Day 15. The VEGFA protein
was localised in intercaruncular luminal, glandular epithelium and in tunica muscularis of blood
vessels. At Day 15, caruncular endometrium displayed higher VEGFA mRNA expression than
intercaruncular endometrium (p < 0.05). Intercaruncular endometrial VEGFA protein at Day 18
was higher in abundance in SCNT than in IVF (p = 0.038). Therefore, during preimplantation in
cattle, there may be a need for timely physiological reduction in intercaruncular endometrial VEGFA
expression in favour of the caruncular area to facilitate a gradient towards the implantation sites.
A higher expression of VEGFA in SCNT may predispose for later placentation abnormalities frequently
observed following SCNT.
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1. Introduction
Early embryonic losses heavily affect bovine reproduction and contribute to low calving rates
(50 to 60%) despite high fertilisation rates (~90%) [1]. During the preimplantation period when the
uterus undergoes vascular changes to create an optimal environment for the rapidly growing demands
of the conceptus, vascular endothelial growth factor A (VEGFA) is a critical angiogenic factor in both
humans and animals [2]. The dimeric glycoprotein VEGFA is a member of the cysteine-knot growth
factor family that include VEGFB, VEGFE, VEGFC, VEGFD and placental growth factor. The VEGFA is
by far the most known potent and pivotal factor for angiogenesis [3,4]. Because of alternative mRNA
splicing of the exons from the VEGFA gene, different VEGFA isoforms are formed. The most abundant
isoforms are VEGFA-121, VEGFA-165 and VEGFA-189 [5]. The isoforms differ first in their heparin
and heparan sulfate-binding abilities [4] and second regarding whether the isoform encodes a pro- or
antiangiogenic protein [5]. Among these three isoforms, VEGFA-165 is the prototypical VEGFA isoform
that induces a robust agonist through the receptor signaling responses and is taken as a reference
isoform for investigating other VEGFA isoforms [6]. Relative to both VEGFA-121 and VEGFA-189,
VEGFA-165 has a higher binding capacity and affinity to induce downstream angiogenic signaling [6–8].
The activities of VEGFA are mediated by the membrane receptors VEGFR-1 and VEGFR-2, which are
the universal regulators of endothelial cell functions [9]. Precisely, VEGFR-1 regulates proliferation
of endothelial cells during angiogenesis and VEGFR-2 is involved in migration and proliferation of
endothelial cells during vessel maintenance [10].
In bovine reproduction, VEGFA substantially contributes to follicular development, functional
maintenance of the corpus luteum, early development of the conceptus and establishment of the
placentation processes [11–13]. Ortega Serrano et al. [14] observed that VEGFA contributes to the
selection of the dominant follicle in dairy cows. Luo et al. [11] showed that 5 ng/mL of recombinant
human VEGFA-165 added to the maturation medium increased both the cleavage rate of bovine oocytes
and the conceptus developmental rate to the 8-cell stage. The recombinant VEGFA-165 treatment in
the latter study had nevertheless no influence on subsequent developmental rates of the 8-cell stage
bovine conceptuses on Days 6, 7 and 8 in vitro. Further, changes in colocalisation of VEGFA in the
vasculature between the implantation stages (from Days 18 to 24) and later stages of gestation in bovine
substantiate the necessity of angiogenesis during implantation [1]. Thus, the importance of VEGFA
during folliculogenesis and early conceptus development until Day 8 and from the implantation stage
(Days 18 to 24) onwards until term has been reported for cattle. The contribution of VEGFA beyond
Day 8 of pregnancy and prior to implantation is yet to be understood. Inferring from the mouse model,
it is possible to disrupt angiogenesis with a single dose of an angiogenesis inhibitor before or shortly
after implantation, resulting in resorption of the conceptuses [2]. Furthermore, during periimplantation
stages in mice, the VEGFA and VEGF receptors are expressed in the endometrium and facilitate
vascular hyperpermeability, which is necessary for blastocyst implantation [2]. The intercaruncular and
caruncular endometrium in bovine are both critical for the development of the conceptus, as they are
the major sites for histotroph synthesis and placentome formation during pregnancy, respectively [15].
Despite recent advances in breeding and biotechnology fields [16,17], techniques such as somatic
cell nuclear transfer (SCNT) still result in low number of live births in cows. Specifically, there are
severe aberrations in vascular development during the early intrauterine development that result in
high embryonic losses of cloned pregnancies [10,16]. Bauersachs et al. [16] as well as Mansouri et al. [18]
suggested that associated placentation malfunctions in clone pregnancies emanate from abnormal
interactions between the conceptus and the endometrium that develop during the preimplantation
phase. Additionally, during second and third trimester, cows carrying SCNT are reported to have
abnormally enlarged and less placental cotyledons, develop hydroallantois and have enlarged umbilical
cords [16].
We aimed at unravelling if the expression of endometrial and embryonic VEGFA isoforms and the
associated receptors are modulated during the preimplantation period in cattle. Furthermore, we tested
the hypothesis that prior to implantation, the caruncular areas display a higher VEGFA abundance to
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prepare for implantation than the intercaruncular endometrium areas. We finally questioned if VEGFA
was altered in heifers gestating cloned conceptuses.
2. Results
2.1. Study A: Cycling versus Pregnant Heifers
2.1.1. The Concentration of P4 and E2 in the Serum of Pregnant and Nonpregnant Heifers
We observed a higher concentration of P4 in the serum of pregnant heifers than nonpregnant
heifers at Days 15 and 18 (p < 0.05). There were no significant differences between the groups in P4
concentrations at Day 12 (Table 1).
High P4 in pregnant heifers at Days 15 and 18 was expected due to the continued secretion of P4
from the corpus luteum in pregnant cattle. Comparing the nonpregnant and pregnant heifers, we did
not find any significant differences in E2 concentrations at Days 12, 15 and 18 post insemination.
Table 1. Progesterone and estradiol-17β concentrations at slaughter in the serum of cyclic and early
pregnant heifers after insemination (insemination = Day 0). Values presented as mean ± standard error
of the mean (SEM). Probability value (p-value) for the respective pairs is given.
Day Status Animals
Progesterone [ng/mL] Estradiol-17β [pg/mL]
Mean ± SEM p-Value Mean ± SEM p-Value
Day 12




pregnant 5 7.83 ± 0.93 3.23 ± 0.56
Day 15




pregnant 6 9.37 ± 0.93 2.81 ± 0.56
Day 18




pregnant 5 10.91 ± 1.02 2.32 ± 0.61
2.1.2. mRNA Expression of VEGFA Isoforms and VEGF Receptors in the Endometrial and Conceptus
Tissues
The pregnancy status of the heifers affected the mRNA expression of endometrial VEGFA-121
(p = 0.045) and VEGFA-189 (p = 0.009) at Day 15 (Figure 1A,C) and VEGFR-1 receptor (p < 0.001) at
Day 18 (Figure 1E).
The mRNA expression was lower in pregnant heifers than in nonpregnant heifers. The endometrial
VEGFA-121 mRNA expression was significantly lower when comparing Day 12 to Day 18 (Figure 1A).
At Day 15, the abundance of VEGFA-121 mRNA was the same as Days 12 and 18 post insemination.
The changes in VEGFA-121 mRNA expression from Days 12 to 18 were similar within the respective
pregnant and nonpregnant groups. For the VEGFR-1 mRNA expression, the transcript abundance was
stable from Days 12 to 15, and decreased (p < 0.001) from Days 15 to 18 overall and within the pregnant
and nonpregnant groups (Figure 1E). The concentration of P4 contributed to the changes in mRNA
expression we observed for VEGFA-121 (p = 0.041) (Figure 1A). Both P4 and E2 concentrations affected
the mRNA expression of the VEGFR-1, p < 0.05 (Figure 1E). The mRNA expression of endometrial
VEGFA-165 and VEGFR-2 was the same according to status and day and was not affected by P4 and E2
concentrations (Figure 1B,F).
The conceptus mRNA expression did not differ between Days 15 and 18 for the VEGFA isoforms
and VEGF receptors (p > 0.05). We further observed that at Day 15, the conceptus VEGFA mRNA
expression in pregnant heifers was similar (VEGFA-121) or higher (VEGFA-165 and VEGFA-189)
than the endometrial VEGFA mRNA expression (Figure 1A–C; folds: 2.1 and 1.7, respectively).
The conceptus mRNA expression of the VEGF receptors was lower in conceptuses than in the
endometrium (Figure 1E,F; folds: 4.1 and 7.1, respectively).
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Figure 1. mRNA expression of vascular endothelial growth factor A (VEGFA) isoforms (A–C),
VEGF receptors (E,F) and VEGFA protein abundance (D) in the intercaruncular endometrium of
nonpregnant (n = 5 to 8) and pregnant (n = 5) Simmental heifers at Days 12, 15 and 18 post insemination
as well as conceptuses at Days 15 (n = 8) and 18 (n = 4) (Insemination = Day 0). Asterisk (*) indicates
significant differences between groups and letters significant differences within nonpregnant (a,b,c)
and pregnant (x,y,z) groups. Abbreviations: P4 = progesterone and E2 = estradiol-17β. Results for
mRNA expression presented as mean delta quantitative cycle (∆Cq) ± standard error of the mean
(SEM). Differences with p < 0.05 were considered as significant.
2.1.3. Endometrial VEGFA Protein Abundance
We observed a difference in VEGFA protein abundance in the endometrium between pregnant
and nonpregnant heifers at Day 15 (p < 0.001). The protein abundance was lower in pregnant than in
nonpregnant heifers (Figure 1D), thus showing a similar pattern as observed for the mRNA expression.
In pregnant heifers, the endometrial VEGFA protein abundance decreased (p = 0.004) from Days 12
to 15 and remained stable until Day 18. In the endometrium of nonpregnant heifers, VEGFA protein
abundance did not differ between Days 12 and 15 but decreased between Days 15 and 18 (p = 0.014).
2.1.4. Localisation of VEGFA in the Endometrium
The VEGFA protein was expressed in the intercaruncular luminal and glandular epithelium
without differing in intensity over time in pregnant and nonpregnant heifers. In addition, endothelial
cells of endometrial capillaries and the tunica media of arterioles stained positive for VEGFA as well
(Figure 2).
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Figure 2. VEGFA immunohistochemistry: an overview of the endometrium (A) and close-up views of
an endometrial gland (B), the luminal epithelium (C) and a blood vessel (D). Insert (A) displays the
negative control where serum was used instead of the primary antibody. All cells stained positive for
vascular endothelial growth factor A without differing in intensity over time between pregnant and
nonpregnant heifers.
2.2. Study B: Caruncular versus Intercaruncular Endometrium in Pregnant Heifers
We assessed the intercaruncular and caruncular endometrial tissues mRNA expression at Day
15 post insemination. The mRNA expression of all VEGFA isoforms at Day 15 in the caruncular
endometrial tissue was higher than the mRNA expression in the intercaruncular endometrial tissue
(p < 0.05) (Figure 3A).
The mRNA expression of VEGFA-165 was higher than the expression of the other two isoforms
(p < 0.001). For the VEGF receptors, the mRNA expression did not differ between intercaruncular
and caruncular endometrial tissues (Figure 3B). Day 15 post insemination total VEGFA protein
abundance was not significantly different between the intercaruncular and caruncular endometrial
tissues (Figure 3C). We only observed a numerical difference, with a higher protein abundance in the
caruncular than in the intercaruncular endometrial tissues (477 ± 104 versus 720 ± 94).
Int. J. Mol. Sci. 2020, 21, 544 6 of 14
Figure 3. Day 15 post insemination vascular endothelial growth factor A (VEGFA) isoforms (A),
VEGF receptors (B) mRNA expression and protein abundance (C) in the intercaruncular endometrial
(ICL) and caruncular endometrial (CL) tissues in pregnant Angus heifers (n = 12). Asterisk (*) indicates
significant differences between tissues (intercaruncular vs. caruncular) for the respective genes and
letters significant differences in mRNA expression within the intercaruncular endometrium (a,b,c) and
the caruncular endometrium (x,y,z) when comparing the genes. Significant differences p < 0.05.
2.3. Study C: SCNT versus IVF Pregnancies
Th gene expression abundance of the VEGFA-165 in the intercaruncular endometrium of heifers
carrying SCNT-derived conceptuses was lower than in the respective endometrium of heifers with
IVF-derived conceptuses at Day 18 (p = 0.045) (Figure 4A). There were no differences in the mRNA
expression of the receptors in the endometrial tissues (Figure 4B).
Contrarily, in the endometrium of heifers gestating SCNT-derived conceptuses, we observed a
higher VEGFA protein abundance than in the endometrium of heifers gestating IVF-derived conceptuses
(p = 0.038) (Figure 4C). The VEGFA protein abundance in the endometrium of the IVF group was
comparable to Day 18 endometrial VEGFA protein abundance of nonpregnant and pregnant heifers
in study A. The mRNA expression of the VEGFA isoforms and receptors in the conceptuses was
not different between SCNT and IVF (Figure 4D,E). We further noted that the mRNA expression
of VEGFA-165 was higher than of VEGFA-121 and VEGFA-189 in both the endometrium and the
conceptuses. The latter observation was consistent in all the three experimental settings (A, B and C).
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Figure 4. Day 18 post insemination vascular endothelial growth factor A (VEGFA) isoforms (A) and
VEGF receptors (B) mRNA expression in the intercaruncular endometrium of heifers gestating the
in vitro fertilised (IVF) and somatic cell nuclear transfer (SCNT) conceptuses. Endometrial VEGFA
protein abundance (C) and conceptus mRNA expression (D,E) are presented (n = 8 for the respective
IVF and SCNT treatments). Asterisk (*) indicates significant differences at p < 0.05.
3. Discussion
We observed that the mRNA expression of the soluble VEGFA-121, membrane bound VEGFA-189
isoforms [19] and the total VEGFA protein abundance in the intercaruncular endometrium were
significantly lower in pregnant than in nonpregnant heifers at Day 15 post insemination. Among other
functions, both VEGFA isoforms promote endothelial cell growth and vascular permeability,
and VEGFA-189 when compared to VEGFA-121 has low mitogenic activity probably due to its
attachment to the extracellular matrix [5,20]. These results suggest that during the preimplantation
period in bovine, there is spatiotemporal physiological reduction in the intercaruncular endometrial
VEGFA, possibly to initiate the implantation process at the caruncular implantation sites. In pigs,
implantation occurs at Day 13 post insemination. The porcine endometrial VEGFA mRNA expression
was shown to be reduced from Days 9 to 12 and then gradually increased from Day 18 of pregnancy
onwards, concurrent with a reduction in VEGF protein at Days 16 and 17 [21]. We noted that the
endometrial VEGFA-121 and VEGFR-1 mRNA expression patterns we analysed in bovine were
comparable to porcine endometrium mRNA expression during the preimplantation period [21].
Thus, freely diffusible VEGFA-121 may possibly play a critical role during the initiation process of
implantation through VEGFR-1 receptor, as speculated earlier [1]. In this study, we observed that
VEGFR-1, which regulates proliferation of endothelial cells during angiogenesis [10], was significantly
reduced at Day 18 in the intercaruncular endometrium of the pregnant heifers. Ferrara et al. [22]
indicated that a mediation function of VEGFR-1 in the vascular endothelium is to induce the release
of tissue specific growth factors in a vascular bed-specific fashion. Thus, VEGFR-1 has the capacity
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to interact with other signal-transducing proteins and competently generate mitogenic signal [22].
The observed reduction in the expression of the bovine VEGFA-121 and VEGFR-1 mRNA in this study
at Days 15 and 18, respectively, could in part be a resultant of higher P4 concentrations in pregnant
heifers at Days 15 and 18 than in the cycling heifers. In gilts, P4 likewise inhibited VEGFA and its
receptor expression in the intercaruncular endometrium [21]. In the present study, we further observed
an additional effect of E2 on P4 on VEGFR-1 mRNA expression. Hayashi et al. [23] suggested that the
bovine endometrium is highly sensitive to peripheral E2 and might thus favour the mRNA expression
of VEGF-family members during the estrous phase. As E2 levels decline post estrus, we found
coincident lower levels of VEGF. Additionally, Tasaki et al. [24] indicated that the bovine endometrial
VEGFR-1 mRNA expression is highest during estrus and the follicular period. A high sensitivity
of the endometrium to hormones is further evidenced by a positive response to the hormone-like
compounds such as prostaglandin E2, which is reported to upregulate VEGFA mRNA expression in
the endometrium in bovine [25]. It is therefore justifiable that though we could only found numerical
differences in E2 concentrations between the nonpregnant and pregnant heifers at Day 18, E2 impacting
on the VEGFR-1 mRNA expression may be possible.
The lack of significant differences between Days 15 and 18 conceptuses for the ligands and
the receptors indicates a potential absence of differential autocrine signaling in the conceptuses via
VEGFA-VEGFR system from Days 15 to 18. Other proangiogenic growth factors such as the fibroblast
growth factors may be comparatively critical between Days 15 and 18. Fibroblast growth factors were
reported to induce the pregnancy recognition signal interferon-tau mRNA expression in vitro [26].
Interferon-tau secretion increases from Days 15 to 18 [25]. Nevertheless, the underlying mechanism
with respect to the synergy between the proangiogenic factors and interferon-tau is yet to be fully
investigated. Interestingly, we noted that the abundance of VEGFA mRNA in the intercaruncular
endometrium was either comparable to (VEGFA-121) or slightly higher (VEGFA-165 and VEGFA-189)
than the conceptus mRNA transcripts. Embryonic VEGFR-1 and -2 displayed a much lower mRNA
expression than the endometrial expression. We therefore propose that the VEGFA of conceptus
origin might affect the VEGF receptors expressed in the endometrium during the preimplantation
phase. This might be necessary for proper interaction between the endometrium and the conceptus
prior to implantation in bovine. In humans, it is known that the conceptus-derived VEGFA induces
vasodilatation and angiogenesis [27]. Additionally, the expression of VEGFA and VEGFR-1 in the
human conceptuses further supports the likely regulatory role of VEGFA on conceptus proliferation,
invasion and associated metabolic activities during implantation [27].
Our consistent observation of high VEGFA-165 expression in the endometrium and the conceptuses
across our three experiments confirms the previous reports that VEGFA-165 is regarded as the
prototypical isoform among the VEGFA isoforms [6–8]. The VEGFA-165 has a higher binding capactiy
to its receptors, heparin and components of the extracellular matrix [6,7]. Peach et al. [6] performed
computational modelling and indicated order of the mRNA abundance is VEGFA-165 > VEGFA-189
> VEGFA-121 in total tissue, extracellular matrix and plasma with VEGFA concentrations of less
than 30 pM. The expression of VEGFA-165 also induced the highest levels of phosphorylation via
VEGFR-2 [6]. In our study, we observed a significant change in VEGFR-1 mRNA expression, which is
considered a decoy receptor to VEGFR-2 due to its decreased tyrosine kinase [6].
The VEGFA protein was localised in the intercaruncular luminal and glandular epithelium
as well as in the tunica muscularis of blood vessels of the cycling and pregnant heifers without
differing in intensity over time. We therefore tested the hypothesis that caruncular endometrial
areas displayed a higher VEGFA abundance in preparation for implantation than intercaruncular
endometrium. The endometrial glands that synthesise the uterine fluid are largely present in the
intercaruncular endometrium, which has been shown to be critical for the development of the
conceptus [15]. The caruncular endometrium, on the other hand, fuses with embryo cotyledons to form
placentome during pregnancy [15]. We also observed significantly higher VEGFA mRNA expression
and a higher numerical difference in protein abundance at Day 15 in the caruncular endometrium
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area that forms part of the embryo-maternal interface. As such, we further affirmed that during
the preimplantation period in cattle, there may be a need for timely physiological reduction in the
intercaruncular endometrial tissue VEGFA expression in favour of caruncular endometrial tissue to
facilitate a gradient towards the implantation sites.
We observed a significantly higher protein abundance in the intercaruncular endometrium of
heifers carrying SCNT than IVF-produced conceptuses at Day 18. The placental failure in bovine cloned
pregnancies has been shown to be a consequence of disrupted conceptus–endometrium signalling
developing during the preimplantation period [16,18]. Mess et al. [10] suggested a compensatory
growth in response to the abnormal vascular development occurring in early pregnancy stages
following an observation of overexpression of the VEGFA in IVF and in SCNT pregnancies [10]. Similar
to previous results [10], we observed a significantly higher VEGFA mRNA expression in the IVF than
SCNT. However, clones show substantial individual differences in differential gene expression [10].
The contrasting results we observed regarding the protein and mRNA expression in the cloned
pregnancies could be due to differences in the posttranscriptional and translational regulation and
protein degradation [28]. There is a higher rate of protein translation than mRNA transcription [28].
Additionally, the half-life of diverse proteins varies from minutes to days while the degradation rate of
mRNA is within hours [28]. Assisted reproductive technologies, in particular SCNT, have been shown
to result in restricted fetal growth in the earlier stages of pregnancy and later an increased growth
in placental tissues until term in humans [10,29]. It appears that in bovine, the accelerated growth
may originate from abnormalities occurring as early as Day 18 post insemination. The abnormality in
cloned pregnancies to some extent could therefore relate to disturbed vascular development during
the preimplantation period, originating from failure in proper embryo–mother communication.
4. Materials and Methods
All experiments were performed with permission from the local veterinary authorities and in
accordance with the acceptable standards regarding treatment and handling of animals. The animal
experiment was conducted in Freising, Germany and approved by the District Government of Upper
Bavaria and was in accordance with the accepted standards of humane animal care in Germany.
4.1. Study A: Cycling versus Pregnant Heifers
4.1.1. Animals and Collection of Samples
Cyclic Simmental heifers of an average age of 23 months were synchronised and treated with
Estrumate (cloprostenol sodium) (500 mg i.m., Essex Tierarznei, Munich, Germany) at diestrus as
previously described [30]. Briefly, after estrous detection, the animals were randomly assigned to their
treatment groups. The pregnant groups (n = 5 per group) were inseminated with cryo-preserved semen
while the nonpregnant control groups (n = 5 to 8 per group) were inseminated with the supernatant
of centrifuged semen from the bull of the same breed. Animals were slaughtered at Days 12, 15 and
18 post insemination (insemination day = Day 0). Blood samples were obtained before slaughter
to determine serum progesterone (P4) and estradiol-17β (E2) levels. Within twenty minutes after
slaughter, the uterus was removed and flushed with phosphate buffered saline (PBS, pH 7.4) for
the recovery of conceptuses. The uterus was longitudinally opened to sample endometrial tissue.
Pregnancy was confirmed by the presence of a conceptus in the uterine lumen. For gene expression
analysis, endometrial tissue samples ipsilateral to the ovary bearing the corpus luteum were sampled
from the lamina propria using a scalpel, as described previously [30]. Tissue sample aliquots for gene
expression analysis were immediately transferred into tubes containing RNA later and managed as
per manufacturer’s instructions (Ambion, Huntington, UK). For determination of endometrial VEGFA
protein levels, tissue sample aliquots were snap-frozen in liquid nitrogen. All samples were stored at
−80 ◦C until further analysis. For localisation of VEGFA in the endometrium, samples were fixed in
Bouin’s solution, washed with ethanol in series and embedded in paraffin [31].
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4.1.2. Analyses of P4 and E2 Concentration in Serum
Levels of progesterone (ng/mL) and estradiol-17β (pg/mL) in the serum were quantified using
an enzyme-linked immunosorbent assay, as described by Prakash et al. [32]. Briefly, 0.5 mL plasma
were mixed with 5 mL of tert-butyl methyl ether mixed with petroleum ether (30/70 v/v; AppliChem,
Darmstadt, Germany) and incubated for two hours at room temperature under constant agitation.
The samples were then stored at −60 ◦C for at least one hour. Thereafter, the supernatant was decanted
and evaporated to dryness using a speed vac (Genevac EZ-2, StepBio, Bologna, Italy). Thereafter,
the dried residues were redissolved in 0.4 mL of assay buffer. The plasma progesterone concentration
was quantified using an enzyme-linked immunosorbent assay. The detection limit of the assay was
0.4 ng/mL. The intra- and inter-assay coefficients of variation were less or equal to 10% and 12%,
in that order.
4.1.3. Gene Expression Analysis of VEGFA Isoforms and VEGF Receptors in Endometrial and
Conceptus Tissues
Total RNA isolation and gene expression analysis were conducted as previously described [30,33].
The total RNA from endometrial and conceptus tissue samples was isolated using TRIzol reagent
(Invitrogen Corporation, Carlsbad, CA, USA). The quality of the RNA was assessed using Agilent
2100 Bioanalyzer (Agilent Technology, Palo Alto, CA, USA). The RNA integrity numbers (RIN) of
the samples were at least 7. The RNA amount was spectrophotometrically determined at 260 nm
by a Nanodrop 1000 ND-1000 (peqLab Biotechnologie GmbH). GoScript™ Reverse Transcription
System kit was used to synthesise complementary DNA (cDNA) as per manufactures instructions
(Promega, Switzerland) and the quantitative PCR reactions were carried out using the LightCycler
DNA Master SYBR Green I protocol (Roche Diagnostics). The gene expression of the target genes was
normalised against the reference gene polyubiquitin (UBQ3) to generate a relative RNA expression
(∆Cq). To avoid negative values while permitting an evaluation of a relative comparison between two
genes, the resulting ∆Cq value was subtracted from an arbitrary value of 20. Thus, high ∆Cq values
represent high transcript abundances. The primer pairs for all the genes analysed are presented in
Table 2.
Table 2. Forward (for) and reverse (rev) primer sequences of the reference gene polyubiquitine, vascular
endothelial growth factor A (VEGFA) isoforms and VEGF receptors (VEGFR-1 and VEGFR-2) for bovine
used in quantitative reverse transcription-PCR.

























4.1.4. VEGFA Protein Concentration in Endometrial Homogenates
Endometrial samples were homogenised in a MagNa Lyser instrument (Roche Applied Science,
Mannheim, Germany) and centrifuged through a NucleoSpin Filter L (Macherey-Nagel GmbH & Co
KG, Düren, Germany). The protein concentrations of endometrial homogenates were determined
using a bicinchoninic acid standard protocol [31]. Endometrial VEGFA protein concentrations were
determined using the commercially available DuoSet Development VEGF ELISA DY293b (R&D
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Systems Inc., Minneapolis, MN, USA) according to the manufacturer’s instructions. Results are
presented as means pg/mg total protein ± standard error of the mean (SEM).
4.1.5. Immunolocalisation of VEGFA in the Bovine Endometrium
Deparaffinised and rehydrated uterine tissue sections (4 µm) were incubated for 15 min in
methanol containing 1% H2O2 to quench endogenous peroxidase. For heat-induced antigen retrieval,
tissue sections were boiled in 0.1 M citrate buffer for 15 min followed by a cooling step for 30 min
at room temperature. Inside a humidified chamber, nonspecific binding was blocked with 10%
goat serum (Dako, Glostrup, Denmark) and washed in PBS with 0.05% Tween20 (PBST) for 30 min.
The primary polyclonal VEGFA IgG antibody (kindly provided by Prof. D. Schams, Weihenstephan,
Germany) directed against each of the bovine VEGFA isoforms (Clone Ka21) was added in a 1:50
dilution on the slides and incubated overnight at 4 ◦C. Upon washing in PBST, the secondary
antirabbit horseradish-conjugated IgG (Sigma-Aldrich, Steinheim, Germany) was added to the slide
in a concentration of 2.5 µg/mL for 30 min. Antibody binding was detected by incubating the slides
in PBST containing 3,3′-diaminobenzidintetrahydrochloride (DAB) and 0.1% H2O2 for 2 to 10 min.
Cell nuclei were stained using Mayer’s Haemalaun (Carl Roth GmbH, Karlsruhe, Germany) prior
to rehydratation and mounting. Microphotographs were taken by using the Zeiss Axioskop 2 and
AxioVision 3.1 Software (Zeiss, Jena, Germany).
4.2. Study B: Caruncular versus Intercaruncular Endometrium in Pregnant Heifers
Cyclic Angus heifers of average age 19 months were supplemented with 450 g of rumen-protected
sunflower oil, rich in omega-6 fatty acids, which affects follicular development and oocyte
competency [33], for a period of 8 weeks (n= 15). The heifers were cycle synchronised, inseminated with
cryo-preserved semen and slaughtered at Day 15 of pregnancy, described in detail by Giller et al. [33].
The tissue sampling was similar to that described for study A. Intercaruncular and caruncular
endometrium was sampled. The intercaruncular and caruncular endometrium areas have both
structural and functional differences regarding pregancy establishment [15]. Samples from pregnant
heifers with a conceptus of 6mm or less were used for further analysis (n = 12). Gene expression
analysis of the VEGFA isoforms and the VEGFR-1 and VEGFR-2 was similar to that described for
study A. The total RNA was isolated using RNA Mini Kit (Qiagen, Hilden, Germany) according to the
manufacturer’s instructions, and the RIN values were at least 5.5. A commercial Bovine VEGF-A ELISA
kit (Merck, Switzerland) was used to quantify the VEGFA protein concentration in the caruncular and
intercaruncular endometrium homogenates as per manufacturer’s instructions.
4.3. Study C: SCNT versus IVF Pregnancies
In vitro fertilisation (IVF) and SCNT procedures were carried out as previously described [16].
Two IVF or two SCNT blastocysts of grade 1 were transferred in estrus-synchronised Simmental
recipient heifer (n = 8 per group) at Day 7 of the estrous cycle and slaughtered at Day 18 of pregnancy.
Uteri were flushed with 100 mL of pre-warmed PBS for the recovery of embryos and endometrial tissue
sampling. The tissue sampling and the SCNT and IVF intercaruncular endometrium and conceptuses
gene expression analysis was performed as described for study A. The normalised ∆Cq value was
subtracted from an arbitrary value of 24. The protein abundance analyses were performed as described
for study B.
4.4. Statistical Analysis
All the statistical tests were performed using IBM SPSS Statistics for Windows, Version 24.0
(Armonk, NY: IBM Corp.), and the data was normally distributed. To evaluate differences in endometrial
gene expression, a linear mixed model was used and the variables in the model were day of the estrous
cycle (Day), pregnancy status [pregnant vs. nonpregnant (Status)] and the interaction between the
day of the cycle and pregnancy status (Day × Status). In study A, the concentration of P4 and E2 at
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slaughter were included as covariates. Bonferroni test was used in posthoc analysis. A t-test was
used to determine the significant differences in conceptus gene expression between Days 15 and 18,
and the gene expression and VEGFA protein abundances between IVF and SCNT pregnancies. Graphs
were plotted using GraphPad Prism for Windows, version 7.03 (GraphPad Software, La Jolla, CA,
USA). The results were considered significantly different when p < 0.05. We further calculated the
fold numerical difference between the endometrium and conceptus normalised ∆Cq in an attempt to
understand the embryo–mother interaction.
5. Conclusions
Taken together, we have bridged the knowledge gap between already known critical functions
of VEGFA and VEGF receptors during folliculogenesis [14], embryogenesis until Day 8 [12] and
maintenance of pregnancy from early implantation period, between Days 18 and 24, to term [1] in
bovine. We have reported novel findings regarding the expression of VEGFA isoforms and VEGF
membrane receptors during the preimplantation period in bovine. We speculate about a contribution
of VEGFA-121 during the initiation process of implantation starting Day 15 via VEGFR-1 receptor
specifically in the caruncular endometrium areas that are the sites of implantation. The higher VEGFA
protein abundance in the intercaruncular endometrium of heifers in response to SNCT embryos may
indicate the placentation abnormalities frequently observed following SCNT.
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